The Terconazole Vaginal Cream, cataloged under National Stock Number 6505-01-290-8950, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Taro Pharmaceuticals U.s.a., Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-290-8950 |
| Primary Part Number | NDC51672-1304-06 |
| Item Name | Terconazole Vaginal Cream |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Taro Pharmaceuticals U.s.a., Inc. |
| Status | ACTIVE |
| Administration | VAGINAL |
| Primary Container Content Quantity | 45.000 GRAMS G |
| Active Ingredient and Strength | 0.400 TERCONAZOLE PERCENTAGE, W/W |
| Primary Container Type | TUBE, COLLAPSIBLE |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC51672-1304-06 PRIMARY | Taro Pharmaceuticals U.s.a., Inc. (USA) |
| NDC00168-0346-46 PRIMARY | Fougera Pharmaceuticals Inc. Dba Pharmaderm Div Fougera/savage Labs/pharmaderm (USA) |
| Reference | Meaning |
|---|---|
| NDC00591-3196-89 | 5/9 Secondary reference Actavis Pharma, Inc. |
| NDC00062-5350-01 | 5/9 Secondary reference Ortho Pharmaceutical Corp Omni Education Div Sub of Johnson and Johnson |
| TERAZOL 7 | 5/9 Secondary reference Ortho Pharmaceutical Corp Omni Education Div Sub of Johnson and Johnson |
NSN 6505-01-290-8950 is a Terconazole Vaginal Cream, manufactured by Taro Pharmaceuticals U.s.a., Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-290-8950 has 2 manufacturer part numbers on file: NDC51672-1304-06 (Taro Pharmaceuticals U.s.a., Inc.), NDC00168-0346-46 (Fougera Pharmaceuticals Inc. Dba Pharmaderm Div Fougera/savage Labs/pharmaderm).
Key specifications for NDC51672-1304-06: Administration: VAGINAL; Primary Container Content Quantity: 45.000 GRAMS G; Active Ingredient and Strength: 0.400 TERCONAZOLE PERCENTAGE, W/W; Primary Container Type: TUBE, COLLAPSIBLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.